TZ Ref No.: TZ-26-1818697
Denmark – Pharmaceutical products – Framework agreement for the purchase of Enhertu (trastuzumab deruxtecan)
Doc ref no.
ted_•••
Sector
Pharmaceuticals
Contract Date
13 Nov 2026
Contract Value
DKK ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The purpose of the framework agreement is to be able to supply the hospital pharmacies of Amgros' stakeholders with the medicine Enhertu (trastuzumab deruxtecan). The capital region's hospital pharmacy also makes purchases for resale in Greenland and the Faroe Islands.